The Hassabis shift and the Dean exit are symptoms. The chip allocation fight is the disease.
Wendy’s Lost Its #2 Ranking. The Stock Has No Floor Yet.
Six straight quarters of U.S. sales declines, a halved dividend, withdrawn guidance, and a new CEO who told Wall Street…